M&A Deal Summary

Agilent Acquires Advanced Analytical Technologies

On March 7, 2018, Agilent acquired information technology company Advanced Analytical Technologies for 250M USD

Acquisition Highlights
  • This is Agilent’s 3rd transaction in the Information Technology sector.
  • This is Agilent’s 8th largest (disclosed) transaction.
  • This is Agilent’s 20th transaction in the United States.
  • This is Agilent’s 1st transaction in Iowa.

M&A Deal Summary
Date 2018-03-07
Target Advanced Analytical Technologies
Sector Information Technology
Buyer(s) Agilent
Deal Type Add-on Acquisition
Deal Value 250M USD

Target

Advanced Analytical Technologies

Ames, Iowa, United States
Advanced Analytical Technologies, Inc. is a provider of capillary electrophoresis-based (CE) solutions for fully-automated analysis of a range of molecules. Advanced Analytical Technologies was founded in 1997 and is based in Ames, lowa.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Agilent

Santa Clara, California, United States
Category Company
Founded 1999
Sector Test/Measurement Equipment
Employees17,600
Revenue 6.8B USD (2023)
DESCRIPTION
Entrance to Agilent's headquarters in Santa Clara, California.
Entrance to Agilent's headquarters in Santa Clara, California.

Agilent is a producer of solutions that includes instruments, software, services, and consumables for the entire laboratory workflow. Agilent's life sciences and applied markets business provide application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Agilent was founded in 1999 and is based in Santa Clara, California.

DEAL STATS #
Overall 26 of 38
Sector (Information Technology) 3 of 3
Type (Add-on Acquisition) 23 of 35
State (Iowa) 1 of 1
Country (United States) 20 of 28
Year (2018) 2 of 7
Size (of disclosed) 8 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-09 Luxcel Biosciences

Cork, Ireland

Luxcel Biosciences is a developer of real-time fluorescence plate-reader based in vitro cell assay kits. Luxcel Biosciences is based in Cork, Ireland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-03 Lasergen

Houston, Texas, United States

Lasergen, Inc. is an emerging biotechnology company focused on research and development of innovative technologies.

Buy $105M
Mergr

Product

Company

Legal